RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

scientific article

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1016657666
P356DOI10.1038/SJ.BJC.6602854
P3181OpenCitations bibliographic resource ID1290372
P932PMC publication ID2361541
P698PubMed publication ID16265349
P5875ResearchGate publication ID7502776

P2093author name stringT Honda
G Tamura
T Motoyama
M Terashima
N Homma
M Endoh
S Nishizuka
P2860cites workRASSF2 is a novel K-Ras-specific effector and potential tumor suppressorQ24301371
Identification of Nore1 as a potential Ras effectorQ24314874
DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancersQ24642645
Ras-induced cellular events (review)Q28138814
The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lungQ28188823
Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epitheliaQ28216984
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.Q30884723
CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.Q33213563
Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epitheliaQ34208622
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancerQ34433428
Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancerQ34507632
Methylation of the RASSF1A gene in human cancersQ34835468
Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epitheliaQ35619062
Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancersQ40630939
Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samplesQ44488217
RAS pathways to cell cycle control and cell transformationQ47716322
Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses.Q53563970
Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes.Q54651323
Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.Q54678246
Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosisQ61627303
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancersQ72992695
Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instabilityQ73264215
Molecular characterization of undifferentiated-type gastric carcinomaQ73757919
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectCpG islandQ1138360
hypermethylationQ106875739
P304page(s)1395-9
P577publication date2005-12-12
P1433published inBritish Journal of CancerQ326309
P1476titleRASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
P478volume93

Reverse relations

cites work (P2860)
Q37420605Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma
Q41202043Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma
Q52663417Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Q39017695Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer
Q45293657Activation of RASSF2A by p300 induces late apoptosis through histone hyperacetylation
Q30491000Analysis of fecal DNA methylation to detect gastrointestinal neoplasia
Q37387487Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer
Q36818078Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer
Q28544810DISIS: prediction of drug response through an iterative sure independence screening
Q37346219DNA methylation and cancer pathways in gastrointestinal tumors
Q53315728Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
Q36414347Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
Q41083940Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix
Q41878340Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients
Q40009864Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.
Q36833529Evaluation of the 3p21.3 tumour-suppressor gene cluster
Q45952950Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2.
Q24301831Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
Q41609967Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect.
Q33559593Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling
Q41135471Hypermethylation of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia
Q40212302Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer
Q102369492Integrated molecular drivers coordinate biological and clinical states in melanoma
Q42184843Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy
Q53099225Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma.
Q54583698Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia.
Q38493190Oral field cancerization: an update on current concepts
Q34326627Pathogenetic mechanisms in gastric cancer
Q34560977Polarization gating spectroscopy of normal-appearing duodenal mucosa to detect pancreatic cancer
Q41231684Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy
Q35609447Prognostic significance of aberrant gene methylation in gastric cancer.
Q38009322RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?
Q24338394RASSF2 associates with and stabilizes the proapoptotic kinase MST2
Q45383714RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level
Q37096218Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma.
Q24336042Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity
Q33604116Spatially resolved optical and ultrastructural properties of colorectal and pancreatic field carcinogenesis observed by inverse spectroscopic optical coherence tomography
Q36383883The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
Q33877015The Ras effector RASSF2 controls the PAR-4 tumor suppressor
Q31121564The Ras-association domain family (RASSF) members and their role in human tumourigenesis
Q47143677The comprehensive expression analysis of circular RNAs in gastric cancer and its association with field cancerization.

Search more.